tirzepatide constipation then diarrhea Why Matters While on GLP-1/GIP-1 Medications Constipation is a common and sometimes underappreciated side effect of GLP-1 and GIP-1 agonists like semaglutide (Wegovy®) or (Zepbound®). Left untreated, it can lead Tirzepatide Diarrhea: Side Effects &

Nikki Battiste has more.

not yet FDA-approved 5.Gastrointestinal side effects (nausea, diarrhea, vomiting) are dose-dependent and similar to other GLP-1 agonists 6.Represents potential next-generation therapy beyond currently approved GLP-1 and GIP/GLP-1 agonists Quick Facts Overview Retatrutide (LY3437943) is a novel peptide therapeutic developed by Eli Lilly that represents the first-in-class triple receptor agonist

Compounded products can be used safely when prepared by reputable, state-licensed compounding pharmacies using pharmaceutical-grade ingredients

Participants will leave with a realistic, compassionate understanding of why responses differ, and practical strategies to combine medication, nutrition, and lymphatic self-care to support better outcomes and quality of life

Have significant medical complexity or multiple comorbidities: If you have multiple chronic conditions, take several medications, or have had complications with weight loss attempts in the past, you may benefit from the closer monitoring and integrated care available through a traditional medical practice rather than a telehealth-only platform

(PubMed) Reljanovic M, Reichel G, Rett K, et al